AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6339154
Drug: Physical exercise
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical exercise (standardized exercise programme, 1 hour twice weekly for 8 months)
Trial: 22429361
Drug: NUTRIOSE® 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NUTRIOSE® 10 g/day for 14 days
Trial: 22429361
Drug: NUTRIOSE® 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NUTRIOSE® 15 g/day for 14 days
Trial: 22429361
Drug: NUTRIOSE® 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NUTRIOSE® 20 g/day for 14 days
Trial: 22429361
Drug: NUTRIOSE® 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NUTRIOSE® 8 g/day for 14 days
Trial: 20463176
Drug: Lactate-guided therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactate-guided therapy (treatment guided by lactate levels aiming to decrease lactate by 20% or more per 2 hours for the initial 8 hours)
Trial: 20463176
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no knowledge of lactate levels during the initial treatment period)
Trial: 19301628
Drug: Hand acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hand acupuncture treatment
Trial: 16306031
Drug: Clarithromycin extended-release
RxNorm normalized name: Clarithromycin Extended-Release Tablets
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin extended-release (ER), 1000 mg once daily
Trial: 16306031
Drug: Clarithromycin immediate-release
RxNorm normalized name: clarithromycin Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin immediate-release (IR), 500 mg bid
Trial: 12410855
Drug: Lisinopril (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (up to 40 mg/day)
Trial: 12410855
Drug: Candesartan (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (up to 32 mg/day)
Trial: 12410855
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (lisinopril up to 20 mg/day plus candesartan up to 16 mg/day)
Trial: 12410855
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy vs Candesartan alone
Trial: 12410855
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy vs Lisinopril only
Trial: 10561307
Drug: Eniluracil 10
RxNorm normalized name: Eniluracil
DrugBank: Eniluracil (DB03516)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eniluracil 10 mg/m(2) twice daily for 3 days before surgery
Trial: 10561307
Drug: Eniluracil treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eniluracil treatment
Trial: 29569535
Drug: Vegetarian diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vegetarian diet combined with daily β-alanine (0.8-0.4 g/d) and creatine supplementation (1 g creatine monohydrate/d) (Veg+Suppl, n=15)
Trial: 26078286
Drug: Alanyl-glutamine-supplemented parenteral
RxNorm normalized name: Alanyl glutamine
DrugBank: Alanyl glutamine (DB11876)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alanyl-glutamine-supplemented parenteral nutrition (Gln-PN)
Trial: 19417589
Drug: Gabadone (amino
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabadone (amino acid preparation)
Trial: 17630491
Drug: Subcutaneous suturing
RxNorm normalized name: oxytetracycline hydrochloride Oral Tablet [5-Way Calf Scour Bolus]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous suturing of the subcutaneous fat tissue
Trial: 17630491
Drug: No subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No subcutaneous suturing of the subcutaneous fat tissue
Trial: 19116707
Drug: Quadrivalent HPV
RxNorm normalized name: HPV, quadrivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrivalent HPV vaccine (types 6, 11, 16, 18)
Trial: 14999536
Drug: N-acetylcysteine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (50 mg kg(‐1) intravenously for 3 days)
Trial: 10660922
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care plus acupressure training and treatment
Trial: 9120912
Drug: Intravesical bacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical bacillus Calmette-Guerin (BCG) therapy with isoniazid (300 mg daily)
Trial: 9120912
Drug: Intravesical bacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical bacillus Calmette-Guerin (BCG) therapy without isoniazid
Trial: 8251274
Drug: Bupivacaine 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 12.5 mg with adrenaline 25 micrograms and sufentanil 10 micrograms (Group A)
Trial: 8251274
Drug: Bupivacaine 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 12.5 mg with adrenaline 25 micrograms and clonidine 30 micrograms (Group B)
Trial: 2418328
Drug: Doxorubicin chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin chemotherapy (60 mg/m2, i.v., given every 3 weeks, up to a maximum dose of 550 mg/m2)
Trial: 11837735
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg intravenous erythromycin
Trial: 31921879
Drug: 42 g
RxNorm normalized name: PETROLATUM 42 g in 100 g TOPICAL OINTMENT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 42 g pistachios
Trial: 31921879
Drug: 100 g
RxNorm normalized name: Berri-Freez 4.5 GM per 100 GM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g whole-wheat bread (WWB)
Trial: 26474232
Drug: Pilates +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilates + physical therapy (PPT)
Trial: 28327054
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy (PT) only
Trial: 24913169
Drug: Single-dose primaquine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose primaquine treatment
Trial: 17975496
Drug: Temsirolimus 25
RxNorm normalized name: temsirolimus 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temsirolimus 25 mg
Trial: 18441625
Drug: Multi sensory
RxNorm normalized name: Parasedge Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi sensory behavior therapy (MSBT) with standard psychiatric inpatient care
Trial: 12168731
Drug: Daily leuprolide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily leuprolide acetate (Group 2)
Trial: 2230623
Drug: Andrographis paniculata
RxNorm normalized name: Andrographis paniculata
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Andrographis paniculata (AP) - single oral dose of 1, 2, 3, and 6 g
Trial: 2230623
Drug: Andrographis paniculata
RxNorm normalized name: Andrographis paniculata
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Andrographis paniculata (AP) - daily doses of 0.12-24 g per kg body weight for six months
Trial: 2230623
Drug: Andrographis paniculata
RxNorm normalized name: Andrographis paniculata
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Andrographis paniculata (AP) - direct assay of anti-bacterial activity in water solution (25,000 mg per litre)
Trial: 31662863
Drug: Lanreotide (LAN)
DrugBank: Lanreotide (DB06791)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lanreotide (LAN) 90 mg
Trial: 27191767
Drug: Advanced formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advanced formulation of megestrol acetate containing nanocrystals (test formulation)
Trial: 27191767
Drug: Conventional formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional formulation of megestrol acetate (reference formulation)
Trial: 22282264
Drug: Both test
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both test and reference formulations
Trial: 24877242
Drug: 22-G SF-EUS-FNA
RxNorm normalized name: zinc oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 22-G SF-EUS-FNA
Trial: 24877242
Drug: 25-G SF-EUS-FNA
RxNorm normalized name: SF-RI 1
DrugBank: Calfactant (DB06415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 25-G SF-EUS-FNA
Trial: 10802000
Drug: sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sublingual nitroglycerin (300 microg)
Trial: 10802000
Drug: low-dose intravenous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: low-dose intravenous isoproterenol (mean infusion rate 1.3 +/- 0.5 microg/min)
Trial: 10802000
Drug: sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sublingual nitroglycerin test
Trial: 10802000
Drug: low-dose isoproterenol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: low-dose isoproterenol test
Trial: 8895233
Drug: Ketamine (bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (bolus at 0.1 mg/kg/5 min followed by an infusion of 7 micrograms/kg/min)
Trial: 6309710
Drug: Neutron irradiation
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutron irradiation twice weekly
Trial: 6309710
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (surgery, photon irradiation, or combined surgery and photon irradiation)
Trial: 26792218
Drug: Concurrent twice‐daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent twice‐daily RT (45 Gy in 30 twice‐daily fractions over 3 weeks)
Trial: 26792218
Drug: Concurrent once‐daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent once‐daily RT (66 Gy in 33 once‐daily fractions over 6.5 weeks)
Trial: 3041354
Drug: Sandoglobulin (immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sandoglobulin (immunoglobulin prepared for intravenous administration)
Trial: 3041354
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with Sandoglobulin
Trial: 3041354
Drug: Parenteral albumin
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral albumin
Trial: 28914720
Drug: Thoracic corrective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic corrective exercise program (1 hour/session, twice per week for 8 weeks, total of 16 sessions)
Trial: 30541093
Drug: Whole-grain wheat
RxNorm normalized name: rice (whole grain) allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-grain wheat (WGW) 98 g/d
Trial: 30541093
Drug: Refined wheat
RxNorm normalized name: WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Refined wheat (RW) 98 g/d
Trial: 24484688
Drug: Subcutaneous hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous hydration (up to 1.5 l/day for 72 hours)
Trial: 24484688
Drug: Intravenous hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydration (up to 1.5 l/day for 72 hours)
Trial: 24484688
Drug: Subcutaneous hydration
RxNorm normalized name: Chloral Hydrate
DrugBank: Chloral hydrate (DB01563)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous hydration
Trial: 22233189
Drug: Very low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Very low-dose naltrexone (VLNTX) 0.125 or 0.25 mg/day
Trial: 22233189
Drug: Very low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Very low-dose naltrexone (VLNTX) + clonidine (0.1-0.2 mg q6h)
Trial: 22233189
Drug: Clonidine (0.1-0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.1-0.2 mg q6h)
Trial: 21054829
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (counselling on daily physical activity, physical fitness training, sports advice)
Trial: 21054829
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment; current policy)
Trial: 17391155
Drug: 0.5% aminophylline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% aminophylline cream applied to the waist twice a day
Trial: 17391155
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (control) applied to the waist
Trial: 15766477
Drug: Kaiku's Benecol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kaiku's Benecol containing 2 g/bottle of plant stanol esters
Trial: 12018956
Drug: Phenobarbitone (prophylactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbitone (prophylactic treatment)
Trial: 9831406
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (bismuth subnitrate 3 x 375 mg for 4 weeks + tetracycline 3 x 500 mg + metronidazole 3 x 250 mg daily for 2 weeks)
Trial: 9831406
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy (amoxicillin 2 x 1000 mg + omeprazole 2 x 20 mg daily for 2 weeks)
Trial: 25265768
Drug: Neostigmine 2.5
RxNorm normalized name: neostigmine 2.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 2.5 mg and atropine 1.2 mg
Trial: 3190971
Drug: No drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drugs to facilitate antagonism of blockade (Control)
Trial: 15480592
Drug: Preparation period
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preparation period of motor acts
Trial: 11247549
Drug: DOTS with
RxNorm normalized name: D3 Dots
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DOTS with direct observation of treatment by health workers
Trial: 11247549
Drug: DOTS with
RxNorm normalized name: D3 Dots
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DOTS with direct observation of treatment by family members
Trial: 7876505
Drug: Oral mesalamine
RxNorm normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral mesalamine (Asacol) 3.2 g/day
Trial: 3284724
Drug: Penicillin and
RxNorm normalized name: Benzathine benzylpenicillin and procaine benzylpenicillin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penicillin and streptomycin (penicillin, 2 ml, IU, intramuscularly, three times daily for six days; streptomycin, 0.5 gm, intramuscularly, two times daily for four days)
Trial: 31180763
Drug: Home-based exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based exercise programme with monthly reinforcement sessions
Trial: 25927495
Drug: Internet-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive behavioral therapy (CBT) program
Trial: 19812871
Drug: Tramiprosate 100
RxNorm normalized name: TRAMIPROSATE
DrugBank: Tramiprosate (DB06527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramiprosate 100 mg
Trial: 19812871
Drug: Tramiprosate 150
RxNorm normalized name: TRAMIPROSATE
DrugBank: Tramiprosate (DB06527)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramiprosate 150 mg
Trial: 14529954
Drug: 325 mg
RxNorm normalized name: lysine 325 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 325 mg lamotrigine (LTG) as a single dose
Trial: 14529954
Drug: bi-hourly graded
RxNorm normalized name: bis-ethoxydiglycol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bi-hourly graded cumulative dose of lamotrigine (LTG)
Trial: 8126258
Drug: Diltiazem 60
RxNorm normalized name: DILTIAZEM 60MG 12HR CAP,SA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 60 mg
Trial: 10716041
Drug: Tolbutamide 500
RxNorm normalized name: tolbutamide 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolbutamide 500 mg
Trial: 7750592
Drug: Ethanol (1
RxNorm normalized name: ALCOHOL 95 mL in 100 mL TOPICAL SOLUTION [95% Ethanol (190 Proof)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (1 mL/kg 95% ethanol)
Trial: 2020905
Drug: Anticoagulant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulant treatment (AC group)
Trial: 2020905
Drug: No anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No anticoagulant treatment (O group)
Trial: 7039927
Drug: Indomethacin (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (0.2 mg/kg for 2 doses, orally, 24 hours apart)
Trial: 29749112
Drug: Technology-enhanced writing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Technology-enhanced writing therapy (12 hours)
Trial: 29749112
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (waitlist, no therapy for 6 weeks)
Trial: 26892695
Drug: 200μg sublingual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200μg sublingual misoprostol
Trial: 26892695
Drug: 400μg sublingual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400μg sublingual misoprostol
Trial: 20155327
Drug: Intensified treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensified treatment (n = 255)
Trial: 20155327
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment according to Dutch guidelines (n = 243)
Trial: 18089478
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (fix combination of 4/1.25 mg perindopril/indapamide)
Trial: 10338459
Drug: valsartan 160
RxNorm normalized name: valsartan 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: valsartan 160 mg BID
Trial: 10338459
Drug: valsartan 80
RxNorm normalized name: valsartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: valsartan 80 mg BID
Trial: 1658183
Drug: Lisinopril 10
RxNorm normalized name: lisinopril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 10 mg daily
Trial: 1658183
Drug: Lisinopril and
RxNorm normalized name: lisinopril and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril and physical training
Trial: 28562099
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone gel 1% (androgel) before Controlled Ovarian Stimulation (COS)
Trial: 28562099
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no testosterone gel)
Trial: 26787797
Drug: Dexketoprofen/tramadol 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexketoprofen/tramadol 25 mg/75 mg
Trial: 25412338
Drug: Glutamine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glutamine (15 g bd) + sitagliptin (100 mg/d)
Trial: 25412338
Drug: Glutamine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glutamine (15 g bd) + placebo
Trial: 17722962
Drug: Tacrolimus once-daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tacrolimus once-daily (OD)
Trial: 17722962
Drug: Standard tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard tacrolimus (twice daily)
Trial: 16221103
Drug: Intravenous cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cyclophosphamide (IVC) 0.75-1 g/m² monthly for 6 months
Trial: 20169461
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) 2 g/day for 6 months
Trial: 21917733
Drug: Intravenous cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cyclophosphamide (IVC)
Trial: 2990196
Drug: 30 ml
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ml of liquid antacid (aluminum and magnesium hydroxide)
Trial: 18241718
Drug: Palatal implants
RxNorm normalized name: malate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palatal implants
Trial: 30903117
Drug: Palatal implants
RxNorm normalized name: malate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palatal implants or mini-screws
Trial: 24151591
Drug: Test product
RxNorm normalized name: Patch test product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test product (cyclobenzaprine tablet)
Trial: 24151591
Drug: Reference product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference product (cyclobenzaprine tablet)
Trial: 11033132
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C (0.2 mg/mL for 2 minutes) with releasable sutures (Group 1)
Trial: 7713197
Drug: MDI containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDI containing lecithin NF (MDI-L)
Trial: 3453431
Drug: Nicergoline (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicergoline (30 mg twice a day) for 6 months (double-blind for PICD patients)